Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab

The combination of all-trans-retinoic acid (ATRA) plus arsenic trioxide (ATO) has been shown to be superior to ATRA plus chemotherapy in the treatment of standard-risk patients with newly diagnosed acute promyelocytic leukemia (APL). A recent study demonstrated the efficacy of this regimen with adde...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Blood
Autores principales: Abaza, Yasmin, Kantarjian, Hagop, Garcia-Manero, Guillermo, Estey, Elihu, Borthakur, Gautam, Jabbour, Elias, Faderl, Stefan, O’Brien, Susan, Wierda, William, Pierce, Sherry, Brandt, Mark, McCue, Deborah, Luthra, Rajyalakshmi, Patel, Keyur, Kornblau, Steven, Kadia, Tapan, Daver, Naval, DiNardo, Courtney, Jain, Nitin, Verstovsek, Srdan, Ferrajoli, Alessandra, Andreeff, Michael, Konopleva, Marina, Estrov, Zeev, Foudray, Maria, McCue, David, Cortes, Jorge, Ravandi, Farhad
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Hematology 2017
Materias:
Clinical Trials and Observations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5413297/
https://ncbi.nlm.nih.gov/pubmed/28003274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-09-736686
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares